Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Authors: Pene, J; Desroches, A; Paradis, L; Lebel, B; Farce, M; Nicodemus, CF; Yssel, H; Bousquet, J
Abstract
Background: Cells producing a T-H2-cytokine profile play an important role in the onset and maintenance of atopic diseases, and therefore specific immunotherapy is aimed to induce a switch to cells producing a T-H1- or T-H0-cytokine profile. Recently, a novel form of immunotherapy making use of synthetic peptides from the major cat allergen Fel d 1 has been developed, but its mechanisms of action are unknown. Objectives: We examined the effects of immunotherapy with Fel dl peptides on the response to bronchial provocation tests (PD20FEV1) with a standardized Fel d 1 cat extract on Fel d 1-specific serum IgE and IgG Levels and in vitro IL-4 and IFN-gamma production. Methods: Patients allergic to cats received 6 weekly injections of 7.5 mu g (Low dose), 75 mu g (medium dose), or 750 mu g (high dose) of Fel d 1 peptides (25 patients) or a placebo (6 patients). Results: Six weeks after ending immunotherapy, posttreatment PD20FEV1 was not significantly different between the treated and placebo groups. However, in the medium- and high-dose groups there was a significant improvement between baseline and posttreatment days. IL-4 release was significantly reduced in the high dose-treated group (P < .005, Wilcoxon W test), whereas it was unchanged in the low or medium dose- and in the placebo-treated groups. In all groups, IFN-gamma, IgE, and IgG levels remained unchanged. Conclusion: There was no correlation between the improvement of PD20FEV1 and the decrease in IL-4 production, These data suggest that peptide immunotherapy may act by shifting, the Fel d 1-induced response of PBMCs in vitro from the T-H2-like to the T-H0-like phenotype.
Cat sensitization according to cat window of exposure in adult asthmatics
CLINICAL AND EXPERIMENTAL ALLERGY
Authors: Oryszczyn, M. -P.; Van Ree, R.; Maccario, J.; Nadif, R.; Kauffmann, F.
Abstract
P>Background In adults, there is limited information on tolerance to cat, which may be reflected by high IgG(4) without IgE sensitization. Early exposure to cat may play a critical role. Objective The aim was to assess among adults the association of Fel d 1 IgG(4), Fel d 1 IgE, skin prick test (SPT) response to cat and pet-related symptoms in relation to exposure to cat considering the period of exposure. Methods SPT response to cat, specific IgE and IgG(4) to Fel d 1 were assessed in 167 asthmatics recruited in chest clinics (40 years of age in average) from the French Epidemiological study on the Genetics and Environment of Asthma (EGEA). Childhood and/or current exposure to cat were studied retrospectively. Results IgG(4) was higher in relation to current cat exposure (0.53 vs. 0.09 ng/mL; P < 0.001) and higher in women than in men. The period of cat exposure was significantly related to Fel d 1 IgE, the IgE/IgG(4) pattern and cat weal size. The lowest values of Fel d 1 IgE, cat weal size, pet-related nasal or respiratory symptoms were observed in those with both childhood and current exposure as well as the highest proportion of the IgE